NCT01725646

An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor® in Taiwanese Hypertriglyceridemic Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 253 (actual)
• Sponsor: Excelsior · Industry
• Sex: All
• Age: 20 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

1. Evaluation of the efficacy of Omacor® in Taiwanese hypertriglyceridemia patients 2. Evaluation of the safety of Omacor® in Taiwanese hypertriglyceridemia patients

Detailed description

The primary end point is to evaluate the efficacy and safety of Omacor in Taiwanese hypertriglyceridemia patients.

Conditions

• Hypertriglyceridemia

Interventions

Type	Name	Description
DRUG	Omacor®	Subjects in 4 g and 2 g Omacor® will take this drug
DRUG	Placebo	Subjects in placebo group will take this drug

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-07-01
• Completion: 2013-08-01
• First posted: 2012-11-14
• Last updated: 2014-05-19

Locations

4 sites across 1 country: Taiwan